Cover Image
市場調查報告書

老年癡呆症診斷檢查裝置:醫療設備的開發平台評估

Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2015

出版商 GlobalData 商品編碼 351350
出版日期 內容資訊 英文 216 Pages
訂單完成後即時交付
價格
Back to Top
老年癡呆症診斷檢查裝置:醫療設備的開發平台評估 Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2015
出版日期: 2016年01月05日 內容資訊: 英文 216 Pages
簡介

本報告提供老年癡呆症診斷檢查裝置的開發中產品相關調查,提供您各開發階段趨勢和產品的主要開發企業,現在進行中的臨床實驗,產業的最近事件等資訊。

第1章 目錄

第2章 簡介

  • 老年癡呆症診斷檢查裝置概要

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:地區 (國家) 別
  • 開發中產品:法規途徑別
  • 開發中產品:核准時期別 (估計)
  • 進行中臨床實驗

第4章 老年癡呆症診斷檢查裝置 - 正在開發的開發中產品:各企業

  • 老年癡呆症診斷檢查裝置的開發企業 - 開發中產品:各開發階段
  • 開發中產品:各開發階段

第5章 老年癡呆症診斷檢查裝置的開發企業與產品概要

  • AC Immune SA
  • Acobiom
  • Acumen Pharmaceuticals, Inc.
  • Adlyfe Inc.
  • Advanced Genomic Technology, LLC
  • ADx NeuroSciences NV
  • Akrivis Technologies, LLC
  • Alere Inc.
  • Alzhyme Pty Ltd
  • Amarantus Bioscience Holdings, Inc.
  • Applied Proteomics, Inc.
  • Araclon Biotech, S.L.
  • Banyan Biomarkers, Inc.
  • BioArctic Neuroscience AB
  • biOasis Technologies Inc.
  • Biomedical Development Corporation
  • BioSystems International
  • C2N Diagnostics LLC
  • Chronix Biomedical, Inc.
  • Cognoptix, Inc.
  • Columbia University
  • CompanDX Ltd.
  • Consejo Superior de Investigaciones Cientificas
  • Cymedx
  • DiaGenic ASA
  • DiamiR LLC
  • DiaPat GmbH
  • Diaxonhit S.A.
  • Dr. Grossegger & Drbal GmbH
  • DS Pharma Biomedical Co., Ltd.
  • Durin Technologies, Inc.
  • Emory University
  • Fianostics GmbH
  • Gene Solutions LLC
  • GeneNews Limited
  • Genentech, Inc.
  • Georg-August-Universitat Gottingen
  • Ghent University
  • HealthTell, Inc.
  • ICDD-sas
  • Innovative California Biosciences International, Inc.
  • Innovative Health Diagnostics
  • Institut National de la Sante et de la Recherche Medicale
  • Instituto de Estructura de la Materia
  • Integrated Diagnostics Inc.
  • Janssen Pharmaceutica N.V.
  • KineMed, Inc.
  • Laboratory Corporation of America Holdings
  • McGill University Health Center
  • Memory Dx, LLC
  • Meso Scale Diagnostics LLC
  • Myriad Genetics, Inc.
  • NanoSomiX, Inc.
  • Nanosphere, Inc.
  • Neuron Biopharma SA
  • NeuroQuest, Ltd.
  • Neurotrope Bioscience, Inc.
  • NeuroVision Imaging LLC.
  • Newcastle University
  • NextGen Sciences Dx Inc
  • Novel Bio-spectrum Technologies, Inc.
  • Oligomerix, inc.
  • OPKO Health, Inc.
  • Orasi Medical, Inc.
  • Oregon Health & Science University
  • Oryzon Genomics S.A.
  • Oxford Biodynamics Limited
  • PDx BioTech
  • PeriRx LLC
  • Pre Diagnostics AS
  • Predemtec GmbH
  • ProMIS Neurosciences Inc.
  • Proplex Technologies, Llc
  • Protagen AG
  • Proteome Sciences Plc
  • Proteomics International Pty Ltd
  • Quanterix Corporation
  • Redox Diagnostics LLC
  • Saladax Biomedical, Inc.
  • Satoris, Inc.
  • Scout Diagnostics, LLC
  • Singulex, Inc.
  • SomaLogic, Inc.
  • Takeda Pharmaceuticals International AG
  • The Johns Hopkins University
  • The University of Melbourne
  • Trinity College Dublin
  • True Diagnostics, Inc.
  • University of California, Irvine
  • University of Chicago
  • University of Georgia
  • University of Luxembourg
  • University of Nottingham
  • University of South Florida
  • University of Texas Health Science Center at Houston
  • University of Texas Southwestern Medical Center at Dallas
  • US Biomarkers, Inc.
  • Vermillion, Inc.
  • Vitruvian Biomedical, Inc.
  • Washington University in St. Louis
  • XRGenomics LTD
  • Zoiray Technologies Inc.

第6章 老年癡呆症診斷檢查裝置 - 最近的事件

第7章 附錄

目錄
Product Code: GDME0143EPD

GlobalData's Medical Devices sector report, "Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2015" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Alzheimer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Alzheimer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Alzheimer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Alzheimer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Alzheimer Diagnostic Tests Overview

3. Products under Development

  • 3.1. Alzheimer - Pipeline Products by Stage of Development
  • 3.2. Alzheimer - Pipeline Products by Territory
  • 3.3. Alzheimer - Pipeline Products by Regulatory Path
  • 3.4. Alzheimer - Pipeline Products by Estimated Approval Date
  • 3.5. Alzheimer - Ongoing Clinical Trials

4. Alzheimer - Pipeline Products under Development by Companies

  • 4.1. Alzheimer Companies - Pipeline Products by Stage of Development
  • 4.2. Alzheimer - Pipeline Products by Stage of Development

5. Alzheimer Companies and Product Overview

  • 5.1. AC Immune SA Company Overview
    • 5.1.1. AC Immune SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Acobiom Company Overview
    • 5.2.1. Acobiom Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Acumen Pharmaceuticals, Inc. Company Overview
    • 5.3.1. Acumen Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Adlyfe Inc. Company Overview
    • 5.4.1. Adlyfe Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Advanced Genomic Technology, LLC Company Overview
    • 5.5.1. Advanced Genomic Technology, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. ADx NeuroSciences NV Company Overview
    • 5.6.1. ADx NeuroSciences NV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Akrivis Technologies, LLC Company Overview
    • 5.7.1. Akrivis Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Alere Inc. Company Overview
    • 5.8.1. Alere Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Alzhyme Pty Ltd Company Overview
    • 5.9.1. Alzhyme Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Amarantus Bioscience Holdings, Inc. Company Overview
    • 5.10.1. Amarantus Bioscience Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Applied Proteomics, Inc. Company Overview
    • 5.11.1. Applied Proteomics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Araclon Biotech, S.L. Company Overview
    • 5.12.1. Araclon Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Banyan Biomarkers, Inc. Company Overview
    • 5.13.1. Banyan Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. BioArctic Neuroscience AB Company Overview
    • 5.14.1. BioArctic Neuroscience AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. biOasis Technologies Inc. Company Overview
    • 5.15.1. biOasis Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Biomedical Development Corporation Company Overview
    • 5.16.1. Biomedical Development Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. BioSystems International Company Overview
    • 5.17.1. BioSystems International Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. C2N Diagnostics LLC Company Overview
    • 5.18.1. C2N Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Chronix Biomedical, Inc. Company Overview
    • 5.19.1. Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Cognoptix, Inc. Company Overview
    • 5.20.1. Cognoptix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. Columbia University Company Overview
    • 5.21.1. Columbia University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. CompanDX Ltd. Company Overview
    • 5.22.1. CompanDX Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. Consejo Superior de Investigaciones Cientificas Company Overview
    • 5.23.1. Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. Cymedx Company Overview
    • 5.24.1. Cymedx Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. DiaGenic ASA Company Overview
    • 5.25.1. DiaGenic ASA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. DiamiR LLC Company Overview
    • 5.26.1. DiamiR LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. DiaPat GmbH Company Overview
    • 5.27.1. DiaPat GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. Diaxonhit S.A. Company Overview
    • 5.28.1. Diaxonhit S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. Dr. Grossegger & Drbal GmbH Company Overview
    • 5.29.1. Dr. Grossegger & Drbal GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. DS Pharma Biomedical Co., Ltd. Company Overview
    • 5.30.1. DS Pharma Biomedical Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. Durin Technologies, Inc. Company Overview
    • 5.31.1. Durin Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32. Emory University Company Overview
    • 5.32.1. Emory University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33. Fianostics GmbH Company Overview
    • 5.33.1. Fianostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34. Gene Solutions LLC Company Overview
    • 5.34.1. Gene Solutions LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35. GeneNews Limited Company Overview
    • 5.35.1. GeneNews Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36. Genentech, Inc. Company Overview
    • 5.36.1. Genentech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37. Georg-August-Universitat Gottingen Company Overview
    • 5.37.1. Georg-August-Universitat Gottingen Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38. Ghent University Company Overview
    • 5.38.1. Ghent University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39. HealthTell, Inc. Company Overview
    • 5.39.1. HealthTell, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40. ICDD-sas Company Overview
    • 5.40.1. ICDD-sas Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41. Innovative California Biosciences International, Inc. Company Overview
    • 5.41.1. Innovative California Biosciences International, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.42. Innovative Health Diagnostics Company Overview
    • 5.42.1. Innovative Health Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.43. Institut National de la Sante et de la Recherche Medicale Company Overview
    • 5.43.1. Institut National de la Sante et de la Recherche Medicale Pipeline Products & Ongoing Clinical Trials Overview
  • 5.44. Instituto de Estructura de la Materia Company Overview
    • 5.44.1. Instituto de Estructura de la Materia Pipeline Products & Ongoing Clinical Trials Overview
  • 5.45. Integrated Diagnostics Inc. Company Overview
    • 5.45.1. Integrated Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.46. Janssen Pharmaceutica N.V. Company Overview
    • 5.46.1. Janssen Pharmaceutica N.V. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.47. KineMed, Inc. Company Overview
    • 5.47.1. KineMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.48. Laboratory Corporation of America Holdings Company Overview
    • 5.48.1. Laboratory Corporation of America Holdings Pipeline Products & Ongoing Clinical Trials Overview
  • 5.49. McGill University Health Center Company Overview
    • 5.49.1. McGill University Health Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.50. Memory Dx, LLC Company Overview
    • 5.50.1. Memory Dx, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.51. Meso Scale Diagnostics LLC Company Overview
    • 5.51.1. Meso Scale Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.52. Myriad Genetics, Inc. Company Overview
    • 5.52.1. Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.53. NanoSomiX, Inc. Company Overview
    • 5.53.1. NanoSomiX, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.54. Nanosphere, Inc. Company Overview
    • 5.54.1. Nanosphere, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.55. Neuron Biopharma SA Company Overview
    • 5.55.1. Neuron Biopharma SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.56. NeuroQuest, Ltd. Company Overview
    • 5.56.1. NeuroQuest, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.57. Neurotrope Bioscience, Inc. Company Overview
    • 5.57.1. Neurotrope Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.58. NeuroVision Imaging LLC. Company Overview
    • 5.58.1. NeuroVision Imaging LLC. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.59. Newcastle University Company Overview
    • 5.59.1. Newcastle University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.60. NextGen Sciences Dx Inc Company Overview
    • 5.60.1. NextGen Sciences Dx Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.61. Novel Bio-spectrum Technologies, Inc. Company Overview
    • 5.61.1. Novel Bio-spectrum Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.62. Oligomerix, inc. Company Overview
    • 5.62.1. Oligomerix, inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.63. OPKO Health, Inc. Company Overview
    • 5.63.1. OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.64. Orasi Medical, Inc. Company Overview
    • 5.64.1. Orasi Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.65. Oregon Health & Science University Company Overview
    • 5.65.1. Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.66. Oryzon Genomics S.A. Company Overview
    • 5.66.1. Oryzon Genomics S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.67. Oxford Biodynamics Limited Company Overview
    • 5.67.1. Oxford Biodynamics Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.68. PDx BioTech Company Overview
    • 5.68.1. PDx BioTech Pipeline Products & Ongoing Clinical Trials Overview
  • 5.69. PeriRx LLC Company Overview
    • 5.69.1. PeriRx LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.70. Pre Diagnostics AS Company Overview
    • 5.70.1. Pre Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview
  • 5.71. Predemtec GmbH Company Overview
    • 5.71.1. Predemtec GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.72. ProMIS Neurosciences Inc. Company Overview
    • 5.72.1. ProMIS Neurosciences Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.73. Proplex Technologies, Llc Company Overview
    • 5.73.1. Proplex Technologies, Llc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.74. Protagen AG Company Overview
    • 5.74.1. Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.75. Proteome Sciences Plc Company Overview
    • 5.75.1. Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.76. Proteomics International Pty Ltd Company Overview
    • 5.76.1. Proteomics International Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.77. Quanterix Corporation Company Overview
    • 5.77.1. Quanterix Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.78. Redox Diagnostics LLC Company Overview
    • 5.78.1. Redox Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.79. Saladax Biomedical, Inc. Company Overview
    • 5.79.1. Saladax Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.80. Satoris, Inc. Company Overview
    • 5.80.1. Satoris, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.81. Scout Diagnostics, LLC Company Overview
    • 5.81.1. Scout Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.82. Singulex, Inc. Company Overview
    • 5.82.1. Singulex, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.83. SomaLogic, Inc. Company Overview
    • 5.83.1. SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.84. Takeda Pharmaceuticals International AG Company Overview
    • 5.84.1. Takeda Pharmaceuticals International AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.85. The Johns Hopkins University Company Overview
    • 5.85.1. The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.86. The University of Melbourne Company Overview
    • 5.86.1. The University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview
  • 5.87. Trinity College Dublin Company Overview
    • 5.87.1. Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
  • 5.88. True Diagnostics, Inc. Company Overview
    • 5.88.1. True Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.89. University of California, Irvine Company Overview
    • 5.89.1. University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview
  • 5.90. University of Chicago Company Overview
    • 5.90.1. University of Chicago Pipeline Products & Ongoing Clinical Trials Overview
  • 5.91. University of Georgia Company Overview
    • 5.91.1. University of Georgia Pipeline Products & Ongoing Clinical Trials Overview
  • 5.92. University of Luxembourg Company Overview
    • 5.92.1. University of Luxembourg Pipeline Products & Ongoing Clinical Trials Overview
  • 5.93. University of Nottingham Company Overview
    • 5.93.1. University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview
  • 5.94. University of South Florida Company Overview
    • 5.94.1. University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.95. University of Texas Health Science Center at Houston Company Overview
    • 5.95.1. University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview
  • 5.96. University of Texas Southwestern Medical Center at Dallas Company Overview
    • 5.96.1. University of Texas Southwestern Medical Center at Dallas Pipeline Products & Ongoing Clinical Trials Overview
  • 5.97. US Biomarkers, Inc. Company Overview
    • 5.97.1. US Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.98. Vermillion, Inc. Company Overview
    • 5.98.1. Vermillion, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.99. Vitruvian Biomedical, Inc. Company Overview
    • 5.99.1. Vitruvian Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.100. Washington University in St. Louis Company Overview
    • 5.100.1. Washington University in St. Louis Pipeline Products & Ongoing Clinical Trials Overview
  • 5.101. XRGenomics LTD Company Overview
    • 5.101.1. XRGenomics LTD Pipeline Products & Ongoing Clinical Trials Overview
  • 5.102. Zoiray Technologies Inc. Company Overview
    • 5.102.1. Zoiray Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview

6. Alzheimer- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Alzheimer - Pipeline Products by Stage of Development
  • Table 2: Alzheimer - Pipeline Products by Territory
  • Table 3: Alzheimer - Pipeline Products by Regulatory Path
  • Table 4: Alzheimer - Pipeline Products by Estimated Approval Date
  • Table 5: Alzheimer - Ongoing Clinical Trials
  • Table 6: Alzheimer Companies - Pipeline Products by Stage of Development
  • Table 7: Alzheimer - Pipeline Products by Stage of Development
  • Table 8: AC Immune SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Abeta-Based Diagnostic Test - Alzheimer´s Disease - Product Status
  • Table 10: Abeta-Based Diagnostic Test - Alzheimer´s Disease - Product Description
  • Table 11: pTau-Based Diagnostic Test - Alzheimer´s Disease - Product Status
  • Table 12: pTau-Based Diagnostic Test - Alzheimer´s Disease - Product Description
  • Table 13: Acobiom Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: Companion Diagnostic Test - Alzheimer's Disease - Product Status
  • Table 15: Companion Diagnostic Test - Alzheimer's Disease - Product Description
  • Table 16: Diagnostic Test - Alzheimer's Disease - Product Status
  • Table 17: Diagnostic Test - Alzheimer's Disease - Product Description
  • Table 18: Acumen Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: Ultra-high Sensitivity Companion Diagnostic Assay - Product Status
  • Table 20: Ultra-high Sensitivity Companion Diagnostic Assay - Product Description
  • Table 21: Adlyfe Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: Diagnostic Assay - Alzheimer's Disease - Product Status
  • Table 23: Diagnostic Assay - Alzheimer's Disease - Product Description
  • Table 24: Advanced Genomic Technology, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: Blood MicroRNA-Based AD Diagnostic And Prognostic Kit - Product Status
  • Table 26: Blood MicroRNA-Based AD Diagnostic And Prognostic Kit - Product Description
  • Table 27: ADx NeuroSciences NV Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: ADDL'S Biomarker Test - Product Status
  • Table 29: ADDL'S Biomarker Test - Product Description
  • Table 30: Alpha-Synuclein Biomarker Test - Product Status
  • Table 31: Alpha-Synuclein Biomarker Test - Product Description
  • Table 32: APO E4 Biomarker Test - Product Status
  • Table 33: APO E4 Biomarker Test - Product Description
  • Table 34: Aß 1-38 CSF Biomarker Test - Product Status
  • Table 35: Aß 1-38 CSF Biomarker Test - Product Description
  • Table 36: Aß 1-40, Aß 1-42, Aß 1-38 Plasma Biomarker Test - Product Status
  • Table 37: Aß 1-40, Aß 1-42, Aß 1-38 Plasma Biomarker Test - Product Description
  • Table 38: BACE 1 Biomarker Test - Product Status
  • Table 39: BACE 1 Biomarker Test - Product Description
  • Table 40: GLOB. P3N Aß Biomarker Test - Product Status
  • Table 41: GLOB. P3N Aß Biomarker Test - Product Description
  • Table 42: Neurofilament Biomarker Test - Product Status
  • Table 43: Neurofilament Biomarker Test - Product Description
  • Table 44: Neurogranin Biomarker Test - Product Status
  • Table 45: Neurogranin Biomarker Test - Product Description
  • Table 46: O-TAU Biomarker Test - Product Status
  • Table 47: O-TAU Biomarker Test - Product Description
  • Table 48: P-tau Biomarker Test - Product Status
  • Table 49: P-tau Biomarker Test - Product Description
  • Table 50: SNAP 25 Biomarker Test - Product Status
  • Table 51: SNAP 25 Biomarker Test - Product Description
  • Table 52: Synuclein Oligo Biomarker Test - Product Status
  • Table 53: Synuclein Oligo Biomarker Test - Product Description
  • Table 54: Akrivis Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 55: Amyloid-ß Biomarker Test - Alzheimer's Disease - Product Status
  • Table 56: Amyloid-ß Biomarker Test - Alzheimer's Disease - Product Description
  • Table 57: Alere Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 58: AD Index - Product Status
  • Table 59: AD Index - Product Description
  • Table 60: Alzhyme Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 61: Diagnostic Test - Alzheimer's Disease - Product Status
  • Table 62: Diagnostic Test - Alzheimer's Disease - Product Description
  • Table 63: Amarantus Bioscience Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 64: Biomarker-Based Diagnostic Assay - Alzheimer's Disease - Product Status
  • Table 65: Biomarker-Based Diagnostic Assay - Alzheimer's Disease - Product Description
  • Table 66: LymPro CLIA Test - Product Status
  • Table 67: LymPro CLIA Test - Product Description
  • Table 68: NuroPro - Alzheimer's Disease - Product Status
  • Table 69: NuroPro - Alzheimer's Disease - Product Description
  • Table 70: Applied Proteomics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 71: API Diagnostic Test - Alzheimer's Disease - Product Status
  • Table 72: API Diagnostic Test - Alzheimer's Disease - Product Description
  • Table 73: Araclon Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 74: AB cbr Diagnostic Test - Product Status
  • Table 75: AB cbr Diagnostic Test - Product Description
  • Table 76: Banyan Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 77: Diagnostic Assay - Alzheimer's Disease - Product Status
  • Table 78: Diagnostic Assay - Alzheimer's Disease - Product Description
  • Table 79: BioArctic Neuroscience AB Pipeline Products & Ongoing Clinical Trials Overview
  • Table 80: Diagnostic Test - Alzheimer's Disease - Product Status
  • Table 81: Diagnostic Test - Alzheimer's Disease - Product Description
  • Table 82: biOasis Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 83: Cognitest - Product Status
  • Table 84: Cognitest - Product Description
  • Table 85: Biomedical Development Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 86: Vestibular - Topographical Memory Diagnostic Test - Product Status
  • Table 87: Vestibular - Topographical Memory Diagnostic Test - Product Description
  • Table 88: BioSystems International Pipeline Products & Ongoing Clinical Trials Overview
  • Table 89: Diagnostic Test - Alzheimer's Disease - Product Status
  • Table 90: Diagnostic Test - Alzheimer's Disease - Product Description
  • Table 91: C2N Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 92: SILK-Aß Assay - Product Status
  • Table 93: SILK-Aß Assay - Product Description
  • Table 94: Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 95: Companion Diagnostic Test - Alzheimer's Disease - Product Status
  • Table 96: Companion Diagnostic Test - Alzheimer's Disease - Product Description
  • Table 97: Cognoptix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 98: SAPPHIRE II Eye Test - Product Status
  • Table 99: SAPPHIRE II Eye Test - Product Description
  • Table 100: Cognoptix, Inc. - Ongoing Clinical Trials Overview
  • Table 101: SAPPHIRE II Eye Test - Diagnosis of Alzheimer's Disease via Beta Amyloid Signature in the Eyes Using SAPPHIRE II : A Proof Of Concept Study
  • Table 102: Columbia University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 103: bAPP Diagnostic Test - Alzheimer's Disease - Product Status
  • Table 104: bAPP Diagnostic Test - Alzheimer's Disease - Product Description
  • Table 105: Diagnostic Test - Alzheimer's Disease - Product Status
  • Table 106: Diagnostic Test - Alzheimer's Disease - Product Description
  • Table 107: CompanDX Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 108: Biomarker Assay - Alzheimer's Disease - Product Status
  • Table 109: Biomarker Assay - Alzheimer's Disease - Product Description
  • Table 110: Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview
  • Table 111: Diagnostic Assay - Alzheimer's Disease - Product Status
  • Table 112: Diagnostic Assay - Alzheimer's Disease - Product Description
  • Table 113: Cymedx Pipeline Products & Ongoing Clinical Trials Overview
  • Table 114: CYMEDX Diagnostic Assay - Alzheimer's Disease - Product Status
  • Table 115: CYMEDX Diagnostic Assay - Alzheimer's Disease - Product Description
  • Table 116: DiaGenic ASA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 117: ADtect PLUS - Product Status
  • Table 118: ADtect PLUS - Product Description
  • Table 119: ADtect ULTRA - Product Status
  • Table 120: ADtect ULTRA - Product Description
  • Table 121: AMYtect - Product Status
  • Table 122: AMYtect - Product Description
  • Table 123: MCItect - New Version - Product Status
  • Table 124: MCItect - New Version - Product Description

List of Figures

  • Figure 1: Alzheimer - Pipeline Products by Stage of Development
  • Figure 2: Alzheimer - Pipeline Products by Territory
  • Figure 3: Alzheimer - Pipeline Products by Regulatory Path
  • Figure 4: Alzheimer - Pipeline Products by Estimated Approval Date
  • Figure 5: Alzheimer - Ongoing Clinical Trials
Back to Top